Acute Kidney Injury Clinical Trials in Pittsburgh, Pennsylvania

3 studies are recruiting for acute kidney injury in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

    This study will enroll adults aged 18 to 80 years diagnosed with sepsis due to a suspected or confirmed bacterial infection, within 7 days of being admitted to the hospital, and who have also developed acute kidney injury within 72 hours of the onset of sepsis. Eligible participants will be randoml…

    Stage
    Phase 2
    Ages
    18 to 80
    Site
    Research Site, Pittsburgh, Pennsylvania
    Locations
    74 in total
    Run by
    AstraZeneca

    See if you can join NCT07215702 on ClinicalTrials.gov

  2. Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial

    This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in in patients with congestive heart failure under…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh, Pennsylvania
    Locations
    3 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT04982419 on ClinicalTrials.gov

  3. Nafamostat Efficacy in Phase 3 Registrational CRRT Study

    A prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at higher risk for blee…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    Locations
    10 in total
    Run by
    Talphera, Inc

    See if you can join NCT06150742 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.